| Predicate |
Object |
| contentType |
Journal Article|Comment |
| endingPage |
388 |
| issn |
1474-4422 |
| issueIdentifier |
5 |
| pageRange |
386-388 |
| publicationName |
The Lancet. Neurology |
| startingPage |
386 |
| bibliographicCitation |
Rudick RA. MS clinical trials: what can subgroup analyses teach us? Lancet Neurol. 2012 May;11(5):386–8. doi: 10.1016/s1474-4422(12)70066-2. PMID: 22494954. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66b85e4b348a66755940622f60c99437 |
| date |
201205 |
| identifier |
https://doi.org/10.1016/s1474-4422%2812%2970066-2
https://pubmed.ncbi.nlm.nih.gov/22494954 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1474-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30413 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
MS clinical trials: what can subgroup analyses teach us? |
| discusses |
http://id.nlm.nih.gov/mesh/M0020302
http://id.nlm.nih.gov/mesh/M0259274
http://id.nlm.nih.gov/mesh/M0017742
http://id.nlm.nih.gov/mesh/M0011171 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D011409Q000627
http://id.nlm.nih.gov/mesh/D007166Q000627
http://id.nlm.nih.gov/mesh/D004185
http://id.nlm.nih.gov/mesh/D020529Q000188
http://id.nlm.nih.gov/mesh/D013110Q000031 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D013110Q000627
http://id.nlm.nih.gov/mesh/D000068876 |